Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 38 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/5/2007


1.		Phase I-II Chemotherapy with Aclacinomycin-A for Advanced Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				over 18								MDA-DT-8125 NCI-W81-0420

Last Modified: 7/1/1997


2.		Phase I-II Chemotherapy with Oral Aclacinomycin for Refractory Cancer of Breast, Ovary, Testis, and Lung, and Malignant Lymphoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								NCI-81-C-116 NCI-MB-162


3.		Phase II Pilot Chemotherapy with Aclacinomycin in Patients with Advanced Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D81-039-464


4.		Phase II Chemotherapy with Aclacinomycin with or without Adriamycin for Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								UMCT-1280


5.		Phase II Chemotherapy with Aclacinomycin-A for Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								WSU-C-40981


6.		Phase II Chemotherapy with Aclacinomycin-A for Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								WSU-C-41081


7.		Phase II Combination Chemotherapy with ACM-A/VP-16 in Patients with Refractory ALL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				URCC-2482M NCI-T83-0984D, T83-0984


8.		Phase II Chemotherapy with Aclacinomycin-A for Advanced, Measurable Gastric Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D81-039-204


9.		Phase II Chemotherapy with Weekly Aclacinomycin for Stage III/IV Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-BRE-81209


10.		Phase II Chemotherapy with Aclacinomycin Every 3 Weeks for Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-BRE-81210

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute